Pancreatic Cancer Research

ResearcherSapporo Medical UniversityActive in the last 2 years

Akira Takasawa

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3244-1199; OpenAlex author ID A5056654750. Sources: OpenAlex.

Their work

Papers
8 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
15
Papers, trials and grants by year

2011: 3 papers · 2012: 1 paper · 2013: 2 papers · 2014: none · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 8

  1. The Role of Claudin-1 in Enhancing Pancreatic Cancer Aggressiveness and Drug Resistance via Metabolic Pathway Modulation. Co-author DOI 10.3390/cancers17091469↗
  2. Nuclear localization of tricellulin promotes the oncogenic property of pancreatic cancer. Co-author DOI 10.1038/srep33582↗
  3. Human equilibrative nucleoside transporter 1 and Notch3 can predict gemcitabine effects in patients with unresectable pancreatic cancer. Co-author DOI 10.1038/bjc.2013.108↗
  4. Protein kinase Cα inhibitor protects against downregulation of claudin-1 during epithelial-mesenchymal transition of pancreatic cancer. Co-author DOI 10.1093/carcin/bgt057↗
  5. Expression of claudins 7 and 18 in pancreatic ductal adenocarcinoma: association with features of differentiation. First author DOI 10.1136/jclinpath-2011-200400↗
  6. Transcriptional regulation of claudin-18 via specific protein kinase C signaling pathways and modification of DNA methylation in human pancreatic cancer cells. Co-author DOI 10.1002/jcb.23095↗
  7. Protein kinase Cα inhibitor enhances the sensitivity of human pancreatic cancer HPAC cells to Clostridium perfringens enterotoxin via claudin-4. Co-author DOI 10.1007/s00441-011-1287-2↗
  8. Downregulation of tight junction-associated MARVEL protein marvelD3 during epithelial-mesenchymal transition in human pancreatic cancer cells. First author DOI 10.1016/j.yexcr.2011.06.020↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Takashi Kojima · 7 shared papers, 2011–2025 · strength 0.42
  2. Daisuke Kyuno · 5 shared papers, 2011–2025 · strength 0.33
  3. Masafumi Imamura · 3 shared papers, 2011–2025 · strength 0.28
  4. Yasutoshi Kimura · 3 shared papers, 2011–2025 · strength 0.28
  5. Makoto Osanai · 2 shared papers, 2016–2025 · strength 0.28
  6. Takumi Konno · 1 shared paper, 2025 · strength 0.22
  7. Norimasa Sawada · 6 shared papers, 2011–2016 · strength 0.19
  8. Koichi Hirata · 5 shared papers, 2011–2016 · strength 0.16
  9. Tatsuya Ito · 4 shared papers, 2011–2013 · strength 0.11
  10. Tsuyoshi Kono · 1 shared paper, 2016 · strength 0.05
  11. Kazunori Eto · 1 shared paper, 2013 · strength 0.03
  12. Taiki Kudo · 1 shared paper, 2013 · strength 0.03
  13. Naoya Sakamoto · 1 shared paper, 2013 · strength 0.03
  14. Masaki Kuwatani · 1 shared paper, 2013 · strength 0.03
  15. Ylermi Soini · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.